Skip to main content
. Author manuscript; available in PMC: 2020 Jul 27.
Published in final edited form as: Nat Nanotechnol. 2020 Jan 27;15(2):145–153. doi: 10.1038/s41565-019-0626-4

Table 1.

Molecular composition of transformable peptide monomers (TPM) 1-4.

TPM BP FFVLK GGAAK YCDGFYACYMDV PEG1000
1 + + +
2 + + +
3 + + +
4 + + +

TPM1 BP-FFVLK-YCDGFYACYMDV (with HER2 binding peptide and β-sheet forming peptide)

TPM2 BP-GGAAK-YCDGFYACYMDV (with HER2 binding peptide, but without β-sheet forming peptide)

TPM3 BP-FFVLK-PEG1000 (without HER2 binding peptide, but with β-sheet forming peptide)

TPM4 BP-GGAAK-PEG1000 (without HER2 binding peptide nor β-sheet forming peptide).